Disease Overview：Male Menopause Syndrome（AP）
Male Andropause Syndrome, also known as Late-Onset Hypogonadism (LOH), is a clinical condition characterized by progressive decline in testosterone levels in aging men—typically after age 40—accompanied by symptoms such as fatigue, decreased libido, erectile dysfunction, mood instability, reduced muscle mass, increased adiposity, and impaired cognitive function. Unlike female menopause, andropause manifests gradually and variably; diagnosis requires integration of validated., ADAM or AMS questionnaires), serum total and free testosterone assays, and exclusion of secondary causes like pituitary disorders or chronic illness. Management emphasizes individualized, evidence-based approaches: lifestyle optimization, testosterone replacement therapy (TRT) via transdermal gels, injections, or pellets—strictly under endocrinologic supervision—and adjunctive interventions for comorbid metabolic or psychological conditions. Untreated LOH correlates with elevated risks of osteoporosis, cardiovascular morbidity, and diminished quality of life.
China offers distinct advantages for international patients seeking comprehensive andropause care. Leading urology and endocrinology centers—many affiliated with Class A tertiary hospitals—employ board-certified specialists trained in male reproductive health and hormonal therapeutics. Advanced diagnostics include LC-MS/MS testosterone quantification, dual-energy X-ray absorptiometry (DEXA) for bone density, and multiparametric penile Doppler ultrasound. Clinical outcomes reflect high adherence to international guidelines (e.g., ISSAM, EAU), with published success rates exceeding 85% in symptom resolution and hormonal normalization over 12-month follow-up. Treatment costs in China are typically 40–60% lower than in the US or Western Europe, without compromising regulatory rigor—TRT protocols comply with NMPA standards and require mandatory baseline prostate-specific antigen (PSA) monitoring and periodic hematocrit assessment. As a dedicated medical tourism agency, we facilitate seamless access: pre-arrival virtual consultations, verified hospital partnerships, transparent all-inclusive pricing (covering diagnostics, TRT initiation, follow-up, and interpreter services), and personalized coordination—from visa support to post-treatment telehealth continuity.
Male Menopause Syndrome: treatment in China helps patients compare specialist hospitals, initial assessment steps and estimated costs that may vary by city, institution and clinical condition.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Male Andropause Syndrome (Androgen Deficiency in Aging Males)
Non-Surgical / Conservative / Medication Options
*Target Criteria:* Confirmed total testosterone <300 ng/dL + consistent symptoms (fatigue, low libido, depression, metabolic dysfunction) after ruling out secondary causes (pituitary disease, chronic illness).
- •Baseline Diagnostic Workup
- •Testosterone Replacement Therapy (TRT)
- *Injectable (testosterone cypionate/enanthate)*: $145–$210/month (100–200 mg/week; includes syringes, alcohol swabs) - *Long-acting injectable (testosterone undecanoate)*: $390–$520 per injection (750 mg every 10–14 weeks; includes administration fee)
- •Adjunctive Therapies
- Selective serotonin reuptake inhibitor (e.g., escitalopram) for comorbid depression: $25–$45/month
Surgical / Procedural / Interventional Options
*Eligibility Criteria:* TRT failure or contraindication (e.g., severe untreated sleep apnea, hematocrit >52%, active prostate cancer), plus documented hypogonadism with pituitary MRI-confirmed microadenoma or testicular failure requiring definitive management.
- •Pituitary Microsurgery (Transnasal Endoscopic)
- Procedure (including anesthesia, OR time, neurosurgeon fee): $4,200–$6,800
- •Testicular Biopsy (Diagnostic)
Special / Complex Condition Management
- •Severe Anemia + Hypogonadism (Hematocrit <30%): Erythropoietin-stimulating agent + TRT titration: $720–$1,150/month
- •Metabolic Syndrome Comorbidity (T2DM, NAFLD): Integrated endocrinology-andrology care (quarterly visits, HbA1c, liver elastography, dual-energy X-ray absorptiometry): $1,350–$1,980/year
Quick Selection Guide
- •Age <50, Mild Symptoms, Budget-Conscious: Start with diagnostic workup ($125–$180) → TRT gel ($220/month); avoid surgery unless MRI-confirmed adenoma.
- •Age 55–70, Moderate–Severe Symptoms, Comorbid Obesity/T2DM: TRT injection ($145/month) + integrated metabolic care ($1,350/year); prioritize lifestyle intervention ($280).
- •Age ≥70, TRT Failure, Elevated Hematocrit/PSA Concerns: Diagnostic testicular biopsy ($320) → referral to endocrinology for non-testosterone anabolic agents (oxandrolone: $380/month) or dose-adjusted TRT under hematology co-management.
- •Any Age with Pituitary Mass on MRI: Proceed directly to preoperative testing ($480–$650) → transnasal microsurgery ($4,200–$6,800); avoid TRT until post-op hormonal recovery assessment.
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Male Menopause Syndrome Medical Vacation Packages
Curated transparent all-inclusive packages combining Male Menopause Syndrome treatment with China top medical destinations:
